Vaccine trial illness unlikely to be linked to shot: Oxford

Bloomberg

Symptoms that prompted the University of Oxford and partner AstraZeneca Plc to pause trials evaluating their experimental coronavirus vaccine probably weren’t related to the shot itself, according to documents sent to participants.
Safety reviews were carried out when participants in the Oxford study developed unexplained neurological symptoms including limb weakness or “changed sensation,” a participant information sheet posted online by Oxford shows.
“After independent review, these illnesses were either considered unlikely to be associated with the vaccine or there was insufficient evidence to say
for certain that the illnesses were or were not related
to the vaccine,” the letter reads.